Belvedere Trading’s Transmedics TMDX Stock Holding History

Belvedere Trading’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,100	Closed	-$166K	–	932
2024 Q2	$166K	Buy	+1,100	New	+$132K	﹤0.01%	376

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Belvedere Trading's TMDX Position: Q2 2021 in Review

Belvedere Trading sold out of Transmedics (TMDX) in Q2 2021, closing a stake of 18,821 shares — an estimated $781K sold.

Belvedere Trading first reported a position in TMDX in Q4 2020 and held it in 2 quarters. The position peaked at $781K in Q1 2021. 123 funds tracked by Wall St. Rank hold TMDX as of Q2 2021.

Belvedere Trading reported no remaining Transmedics position as of Q2 2021 after selling out during the quarter.
Belvedere Trading sold 18,821 Transmedics shares in Q2 2021, an estimated $781K.
Belvedere Trading first reported a position in Transmedics in Q4 2020 and held it in 2 quarters.
Belvedere Trading's Transmedics position peaked at $781K in Q1 2021.
123 funds tracked by Wall St. Rank held Transmedics as of Q2 2021.

Based on Belvedere Trading's 13F filing for Q2 2021, filed 23 Jul 2021.